Consistent with the findings from transcriptome analysis and phenotypic changes in invasion properties, Western blot and RT-qPCR analyses revealed that NRXN1 knockdown promotes EMT in CRC cells. This evidence concerns the gene NRXN1 and colorectal carcinoma.